What drugs does SOMERSET make?

SOMERSET has 19 FDA-approved drugs including BRIMONIDINE TARTRATE AND TIMOLOL MALEATE, CALCIUM CHLORIDE 10%.

What therapeutic areas does SOMERSET focus on?

SOMERSET focuses primarily on Cardiovascular and Ophthalmology and 1 other therapeutic areas.

Data updated: Mar 10, 2026

SOMERSET

CardiovascularOphthalmologyNeurology

Generics

SOMERSET is a generic drug manufacturer focused on Cardiovascular, Ophthalmology, Neurology. Key products include DEXMEDETOMIDINE HYDROCHLORIDE.

2006

Since

Drugs

Trials

141

Approved (2yr)

Key Drugs

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

brimonidine tartrate

Ophthalmology

alpha-2 adrenergic receptor 2 indications · 2022

CALCIUM CHLORIDE 10%

calcium chloride

· 2017

Recent Activity

DEXMEDETOMIDINE HYDROCHLORIDE 2026-02-17

Labeling

SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10

Labeling

ATROPINE SULFATE 2026-02-04

Labeling

LATANOPROST 2026-01-30

Labeling

LATANOPROST 2026-01-30

Labeling

LATANOPROST 2026-01-30

Labeling

CUPRIC CHLORIDE 2026-01-26

OLOPATADINE HYDROCHLORIDE 2026-01-06

LATANOPROST 2025-12-17

VERAPAMIL HYDROCHLORIDE 2025-11-24

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 56%

5 drugs

Ophthalmology 33%

3 drugs

Neurology 11%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Novartis big-pharma

Cardiovascular, Ophthalmology

UPJOHN big-pharma

Neurology, Cardiovascular, Ophthalmology

Baxter specialty

Cardiovascular, Ophthalmology

AbbVie big-pharma

Neurology, Ophthalmology

Bayer big-pharma

Cardiovascular, Ophthalmology

SOMERSET

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (19)

Active (13)

Discontinued (4)

Company Info